Role of interleukin 10 during persistent infection with the relapsing fever spirochete Borrelia turicatae

American Journal of Pathology

Volumn 170, Issue 1, 2007, Pages 251-262

  Gelderblom, Harald ^a,b,d   Schmidt, Jens ^b   Londoño, Diana ^d   Bai, Yunhong ^d   Quandt, Jacqueline ^a   Hornung, Ron ^c   Marques, Adriana ^a   Martin, Roland ^a   Cadavid, Diego ^d  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c SAIC FREDERICK INC   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; RAG1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BORRELIA INFECTION; BORRELIA TURICATAE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; MOUSE; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; SEROTYPING; SPIROCHETE; UPREGULATION; ANIMAL; BORRELIA; COMPARATIVE STUDY; DOWN REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; BORRELIA; BORRELIA INFECTIONS; DISEASE PROGRESSION; DOWN-REGULATION; IMMUNITY, NATURAL; INFLAMMATION; INTERLEUKIN-10; MICE; RELAPSING FEVER; T-LYMPHOCYTES;

EID: 33847011062     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.060407     Document Type: Article

References (37)

1. Southern P, Sanford J: Relapsing fever. Medicine 1969, 48:129-149
2. Barbour AG, Hayes SF: Biology of Borrelia species. Microbiol Rev 1986, 50:381-400
3. Cadavid D, Thomas DD, Crawley R, Barbour AG: Variability of a bacterial surface protein and disease expression in a possible mouse model of systemic Lyme borreliosis. J Exp Med 1994, 179:631-642
4. Barbour AG, Tessier SL, Stoenner HG: Variable major proteins of Borrellia hermsii. J Exp Med 1982, 156:1312-1324
5. Connolly SE, Benach JL: Cutting edge: the spirochetemia of murine relapsing fever is cleared by complement-independent bactericidal antibodies. J Immunol 2001, 167:3029-3032
6. Alugupalli KR, Gerstein RM, Chen J, Szomolanyi-Tsuda E, Woodland RT, Leong JM: The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes. J Immunol 2003, 170:3819-3827
7. Cadavid D, Pennington PM, Kerentseva TA, Bergstrom S, Barbour AG: Immunologic and genetic analyses of VmpA of a neurotropic strain of Borrelia turicatae. Infect Immun 1997, 65:3352-3360
8. Cadavid D, Pachner AR, Estanislao L, Patalapati R, Barbour AG: Isogenic serotypes of Borrelia turicatae show different localization in the brain and skin of mice. Infect Immun 2001, 69:3389-3397
9. Cooper PJ, Fekade D, Remick DG, Grint P, Wherry J, Griffin GE: Recombinant human interleukin-10 fails to alter proinflammatory cytokine production or physiologic changes associated with the Jarisch-Herxheimer reaction. J Infect Dis 2000, 181:203-209
10. Fekade D, Knox K, Hussein K, Melka A, Lalloo DG, Coxon RE, Warrell DA: Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha. N Engl J Med 1996, 335:311-315
11. Pennington PM, Cadavid D, Barbour AG: Characterization of VspB of Borrelia turicatae, a major outer membrane protein expressed in blood and tissues of mice. Infect Immun 1999, 67:4637-4645
12. Cadavid D, Bundoc V, Barbour AG: Experimental infection of the mouse brain by a relapsing fever Borrelia species: a molecular analysis. J Infect Dis 1993, 168:143-151
13. Nishio R, Matsumori A, Shioi T, Ishida H, Sasayama S: Treatment of experimental viral myocarditis with interleukin-10. Circulation 1999, 100:1102-1108
14. Schmidt J, Metselaar JM, Gold R: Intravenous liposomal prednisolone downregulates in situ TNF-alpha production by T-cells in experimental autoimmune encephalomyelitis. J Histochem Cytochem 2003, 51:1241-1244
15. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25:402-408
16. Barbour AG, Burman N, Carter CJ, Kitten T, Bergstrom S: Variable antigen genes of the relapsing fever agent Borrelia hermsii are activated by promoter addition. Mol Microbiol 1991, 5:489-493
17. Negussie Y, Remick DG, DeForge LE, Kunkel SL, Eynon A, Griffin GE: Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch-Herxheimer reaction of relapsing fever. J Exp Med 1992, 175:1207-1212
18. Cuevas LE, Borgnolo G, Hailu B, Smith G, Almaviva M, Hart CA: Tumour necrosis factor, interleukin-6 and C-reactive protein in patients with louse-borne relapsing fever in Ethiopia. Ann Trop Med Parasitol 1995, 89:49-54
19. Vidal V, Scragg IG, Cutler SJ, Rookett KA, Fekade D, Warrell DA, Wright DJ, Kwiatkowski D: Variable major lipoprotein is a principal TNF-inducing factor of louse-borne relapsing fever. Nat Med 1998, 4:1416-1420
20. Newman Jr K, Johnson RC: In vivo evidence that an intact lytic complement pathway is not essential for successful removal of circulating Borrelia turicatae from mouse blood. Infect Immun 1981, 31:465-469
21. McKisic MD, Redmond WL, Barthold SW: Cutting edge: T cell-mediated pathology in murine Lyme borreliosis. J Immunol 2000, 164:6096-6099
22. Newman Jr K, Johnson RC: T-cell-independent elimination of Borrelia turicatae. Infect Immun 1984, 45:572-576
23. Connolly SE, Thanassi DG, Benach JL: Generation of a complement- independent bactericidal IgM against a relapsing fever Borrelia. J Immunol 2004, 172:1191-1197
24. Purswani MU, Eckert SJ, Arora HK, Noel GJ: Effect of ciprofloxacin on lethal and sublethal challenge with endotoxin and on early cytokine responses in a murine in vivo model. J Antimicrob Chemother 2002, 50:51-58
25. Brubaker RR: Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen). Infect Immun 2003, 71:3673-3681
26. Rasley A, Tranguch SL, Rati DM, Marriott I: Murine glia express the immunosuppressive cytokine, interleukin-10, following exposure to Borrelia burgdorferi or Neisseria meningitidis. Glia 2006, 53:583-592
27. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19:683-765
28. Brown JP, Zachary JF, Teuscher C, Weis JJ, Wooten RM: Dual role of interleukin-10 in murine Lyme disease: regulation of arthritis severity and host defense. Infect Immun 1999, 67:5142-5150
29. Kuhlow CJ, Garcia-Monco JC, Coleman JL, Benach JL: Murine microglia are effective phagocytes for Borrelia burgdorferi. J Neuroimmunol 2005, 168:183-187
30. Gjertsson I, Hultgren OH, Tarkowski A: Interleukin-10 ameliorates the outcome of Staphylococcus aureus arthritis by promoting bacterial clearance. Clin Exp Immunol 2002, 130:409-414
31. Rupprecht T, Pfister HW, Angele B, Kastenbauer S, Wilske B, Koedel U: The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurology 2005, 65:448-450
32. Giambartolomei GH, Dennis VA, Lasater BL, Philipp MT: Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14. Infect Immun 1999, 67:140-147
33. Giambartolomei GH, Dennis VA, Lasater BL, Murthy PK, Philipp MT: Autocrine and exocrine regulation of interleukin-10 production in THP-1 cells stimulated with Borrelia burgdorferi lipoproteins. Infect Immun 2002, 70:1881-1888
34. Van Voorhis WC, Barrett LK, Koelle DM, Nasio JM, Plummer FA, Lukehart SA: Primary and secondary syphilis lesions contain mRNA for Th1 cytokines. J Infect Dis 1996, 173:491-495
35. Wicher V, Scarozza AM, Ramsingh AI, Wicher K: Cytokine gene expression in skin of susceptible guinea-pig infected with Treponema pallidum. Immunology 1998, 95:242-247
36. Weis JJ, Ma Y, Erdile LF: Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification. Infect Immun 1994, 62:4632-4636
37. Londoño D, Bai Y, Zuckert WR, Gelderblom H, Cadavid D: Cardiac apoptosis in severe relapsing fever borreliosis. Infect Immun 2005, 73:7669-7676